NCT06196593

Visual Outcomes Following Bilateral Implantation of the Vivity Toric Intraocular Lens

Visual Outcomes Following Bilateral Implantation of a Non-diffractive Wavefront-shaping Extended Depth of Focus Toric Intraocular Lens

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: LEC Eye Centre · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study was to evaluate the clinical and patient reported outcomes after bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens.

Detailed description

This is a prospective interventional case series of 30 patients who underwent cataract surgery and bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens. This study is represented by an Asian cohort of patients and the study evaluations were focused not only on clinical visual outcomes but also on "real-life" patient reported outcomes such as dysphotopsias, spectacle independence and daily visual tasks all of which were measured at 1 month and up to 3 months postoperatively. The objective would be to provide insight into the performance of this intraocular lens in Asian patients.

Conditions

• Cataract Senile
• Intraocular Lens Complication

Interventions

Type	Name	Description
DEVICE	AcrySof™ IQ Vivity™ Toric intraocular lens	Uneventful phacoemulsification and implantation of IOL

Timeline

• Start date: 2022-04-01
• Primary completion: 2023-04-30
• Completion: 2023-04-30
• First posted: 2024-01-09
• Last updated: 2024-01-09

Locations

1 site across 1 country: Malaysia

Regulatory

• FDA-regulated device study